| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M006545200 |
| P698 | PubMed publication ID | 11035013 |
| P2093 | author name string | Nagai R | |
| Arai H | |||
| Horiuchi S | |||
| Nakayama H | |||
| Kuniyasu A | |||
| Ohgami N | |||
| Ikemoto M | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3195-3202 | |
| P577 | publication date | 2000-10-16 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products | |
| P478 | volume | 276 |
| Q42653520 | A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation |
| Q84801811 | AGE-modified collagens I and III induce keratinocyte terminal differentiation through AGE receptor CD36: epidermal-dermal interaction in acquired perforating dermatosis |
| Q44198123 | Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain |
| Q42811828 | Adipocytes recognize and degrade oxidized low density lipoprotein through CD36. |
| Q35749244 | Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis |
| Q50690444 | Advanced glycation end products attenuate the function of tumor necrosis factor-like weak inducer of apoptosis to regulate the inflammatory response. |
| Q30518002 | Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36. |
| Q35067948 | Advanced glycation endproducts and osteoarthritis |
| Q41856043 | Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation). |
| Q43270496 | Aggregates of denatured proteins stimulate nitric oxide and superoxide production in macrophages |
| Q40219950 | Binding of Plasmodium falciparum to CD36 can be shielded by the glycocalyx. |
| Q41935783 | CD36 in chronic kidney disease: novel insights and therapeutic opportunities |
| Q77712197 | CD36, serves as a receptor for advanced glycation endproducts (AGE) |
| Q42804734 | CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes |
| Q24678338 | CD36: implications in cardiovascular disease |
| Q42266144 | DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q45151232 | Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products |
| Q29302052 | Dry roasting enhances peanut-induced allergic sensitization across mucosal and cutaneous routes in mice |
| Q38288068 | Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates. |
| Q41940233 | Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress. |
| Q48686111 | Engulfment of spermatozoa by cumulus cells and the role of CD36 |
| Q41583979 | Food Processing: The Influence of the Maillard Reaction on Immunogenicity and Allergenicity of Food Proteins |
| Q38769631 | Glycated LDL increase VCAM-1 expression and secretion in endothelial cells and promote monocyte adhesion through mechanisms involving endoplasmic reticulum stress. |
| Q36115715 | Glycation and insulin resistance: novel mechanisms and unique targets? |
| Q34800437 | Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options |
| Q41901281 | High-density lipoprotein increases the uptake of oxidized low density lipoprotein via PPARγ/CD36 pathway in inflammatory adipocytes |
| Q60786622 | Human serum albumin minimally modified by methylglyoxal binds to human mononuclear leukocytes via the RAGE receptor and is displaced by Nε-carboxymethyl-lysine and hydroimidazolone AGE epitopes |
| Q57110548 | Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs) |
| Q33186938 | Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products |
| Q35164047 | Involvement of Maillard reactions in Alzheimer disease |
| Q35797182 | Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts |
| Q77578272 | Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE) |
| Q92702386 | Lipid Accumulation and Chronic Kidney Disease |
| Q36963139 | Macrophage scavenger receptors and host-derived ligands |
| Q37207007 | Macrophages in neovascular age-related macular degeneration: friends or foes? |
| Q41159790 | Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity. |
| Q37036184 | N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status. |
| Q44640723 | Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells |
| Q46738694 | Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury. |
| Q37635868 | Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity |
| Q34803791 | OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36 |
| Q36637912 | PPAR γ Networks in Cell Signaling: Update and Impact of Cyclic Phosphatidic Acid |
| Q38228956 | Pattern recognition receptors and central nervous system repair. |
| Q89459556 | Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer's Disease: A Hypothesis |
| Q36635410 | RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice |
| Q35854488 | RAGE: a novel target for drug intervention in diabetic vascular disease |
| Q38950436 | Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis. |
| Q89634122 | Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases |
| Q45227243 | Renal clearance of glycolaldehyde- and methylglyoxal-modified proteins in mice is mediated by mesangial cells through a class A scavenger receptor (SR-A). |
| Q35803078 | S100 proteins in cartilage: role in arthritis |
| Q34963742 | Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system |
| Q41923200 | Statins decrease vascular epithelial growth factor expression via down-regulation of receptor for advanced glycation end-products |
| Q90702402 | Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice? |
| Q34470639 | The AGE-receptor in the pathogenesis of diabetic complications |
| Q49299877 | The Association Between Variants of Receptor for Advanced Glycation End Products (RAGE) Gene Polymorphisms and Age-Related Macular Degeneration |
| Q38023062 | The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes. |
| Q77530330 | The liver is the main site for metabolism of circulating advanced glycation end products |
| Q63241252 | The physiological scavenger receptor function of hepatic sinusoidal endothelial and Kupffer cells is independent of scavenger receptor class A type I and II |
| Q34273619 | The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders |
| Q34206401 | Transition metals redox: reviving an old plot for diabetic vascular disease |
| Q34228219 | Uptake and accumulation of oxidized low-density lipoprotein during Mycobacterium tuberculosis infection in guinea pigs |
Search more.